Ember Therapeutics, Inc. (EMBT)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2014 | 2013 | 2012 |
|---|---|---|---|
| Revenue | - | - | - |
| Cost of Revenue | - | - | - |
| Gross Profit | - | - | - |
| Operating Expenses | 17.42 Thousand | 11.07 Thousand | 7869.00 |
| Selling, General and Administrative Expenses | 17.42 Thousand | 11.07 Thousand | 7869.00 |
| Research and Development Expenses | - | - | - |
| Other Expenses | - | - | - |
| Cost and Expenses | 17.42 Thousand | 11.07 Thousand | 7869.00 |
| Operating Income | -17.42 Thousand | -11.07 Thousand | -7869.00 |
| Interest Expense | 5821.00 | - | - |
| Income Tax Expense | - | - | - |
| Earnings before Tax | -23.24 Thousand | -16.33 Thousand | -12.78 Thousand |
| Net Income | -23.24 Thousand | -16.33 Thousand | -12.78 Thousand |
| Earnings Per Share Basic | -0.01 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.01 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 3.7 Million | 3.7 Million | 3.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.7 Million | 3.7 Million | 3.7 Million |
| Gross Margin | - | - | - |
| EBIT Margin | - | - | - |
| Profit Margin | - | - | - |
| EBITDA | -17.42 Thousand | -11.07 Thousand | -7869.00 |
| Earnings Before Tax Margin | - | - | - |
| Breakdown | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 FY | 2014 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | -252.00 | 5844.00 | 3790.00 | 4548.00 | 17.42 Thousand | 3923.00 |
| Selling, General and Administrative Expenses | 252.00 | 5844.00 | 3790.00 | 4548.00 | - | 3923.00 |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | -252.00 | 5844.00 | 3790.00 | 4548.00 | 17.42 Thousand | 3923.00 |
| Operating Income | 252.00 | -5844.00 | -3790.00 | -4548.00 | -17.42 Thousand | -3923.00 |
| Interest Expense | 1603.00 | 1556.00 | 1490.00 | - | 5821.00 | - |
| Income Tax Expense | - | - | - | - | - | - |
| Earnings before Tax | -1351.00 | -7400.00 | -5280.00 | -6064.00 | -23.24 Thousand | -5418.00 |
| Net Income | -1351.00 | -7400.00 | -5280.00 | -6064.00 | -23.24 Thousand | -5418.00 |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | - | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | - | -0.00 |
| Weighted Average Shares Outstanding | 3.7 Million | 3.7 Million | 3.7 Million | 3.7 Million | 3.7 Million | 3.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.7 Million | 3.7 Million | 3.7 Million | 3.7 Million | 3.7 Million | 3.7 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | 252.00 | -5844.00 | -3790.00 | -4548.00 | - | -3923.00 |
| Earnings Before Tax Margin | - | - | - | - | - | - |
FIP
HLOC
SANDHAR
LILAB
3666
GNRV